PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $652,467 | -43.6% | 29,115 | +2.4% | 0.06% | -42.3% |
Q2 2023 | $1,155,963 | -15.9% | 28,423 | +0.2% | 0.10% | -23.0% |
Q1 2023 | $1,373,855 | +27.9% | 28,362 | +0.8% | 0.14% | +21.6% |
Q4 2022 | $1,074,256 | -25.1% | 28,144 | -1.5% | 0.11% | -24.0% |
Q3 2022 | $1,434,000 | +42.7% | 28,565 | +13.9% | 0.15% | +46.0% |
Q2 2022 | $1,005,000 | +7.8% | 25,077 | +0.4% | 0.10% | +25.0% |
Q1 2022 | $932,000 | -5.1% | 24,977 | +1.3% | 0.08% | +1.3% |
Q4 2021 | $982,000 | +9.0% | 24,657 | +1.8% | 0.08% | -2.5% |
Q3 2021 | $901,000 | -11.1% | 24,220 | +1.0% | 0.08% | -12.9% |
Q2 2021 | $1,013,000 | -10.4% | 23,975 | +0.3% | 0.09% | -16.2% |
Q1 2021 | $1,131,000 | -23.4% | 23,892 | -1.3% | 0.11% | -29.3% |
Q4 2020 | $1,477,000 | +30.5% | 24,199 | -0.1% | 0.16% | +12.1% |
Q3 2020 | $1,132,000 | -19.8% | 24,221 | -12.9% | 0.14% | -19.1% |
Q2 2020 | $1,411,000 | +29.3% | 27,811 | +13.7% | 0.17% | +25.4% |
Q1 2020 | $1,091,000 | -40.3% | 24,464 | -35.8% | 0.14% | -14.3% |
Q4 2019 | $1,829,000 | – | 38,081 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |